Brieflist

Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics

Forecast: not open for applications yet. Dates are the funder's estimate. Save a search and Brieflist marks it when it opens (Grants Pro e-mails you), or get the free weekly digest:

This is a forecast: the funder has announced the grant but applications are not open yet. Dates may change.

The goal of this funding opportunity announcement is to support applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics.

Read the official page on Grants.gov ↗ Get new grants like this

Funder
Food and Drug Administration (Department of Health and Human Services)
Where
🇺🇸 United States
Status
Forecast
Funding
Not stated
Expected awards
2
Who can apply
Most organisations
Topics
Agriculture & food Justice & security
Opportunity number
FOR-FD-25-015
Instrument
Cooperative agreement

About this grant

The goal of this funding opportunity announcement is to support applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics. The main outcomes of this work will be publications and presentations; however, FDA staff anticipate substantial involvement in study design and reviewing interim deliverables to ensure that the studies develop practical approaches and solutions that have the potential to inform regulatory decision making in the future. We anticipate organizing regular calls with funded investigators to support the collaboration with FDA - reviewing annual reports would be insufficient to ensure that direction of the research addresses FDA's needs.

OCE is interested in supporting research that improve the detection, monitoring and treatment of cardiotoxicity of oncology therapeutics.

Specific areas of interest include:

-Standardize Definitions: Develop clear definitions for different types and grades of cardiotoxicity

-Biomarkers and Imaging: Standardize the use of biomarkers and imaging techniques for assessing cardiotoxicity in oncology trials

-Functional Measures: Define consistent criteria for evaluating cardiac function

-Monitoring Plan: Develop a standardized cardiotoxicity monitoring plan that specifies the timing of cardiac assessments during the trial.

-Risk Stratification: Use a risk stratification model to identify patients at higher risk for cardiotoxicity based on pre-existing conditions and treatment regimens.

-Electronic Health Records and Real-World Data: Utilize electronic health records to standardize and systematically collect and store cardiotoxicity data, ensuring data accuracy and completeness.

-Patient-Reported Outcomes: Integrate patient-reported outcomes related to cardiovascular health (e.g., symptoms of heart failure, quality of life).

-Collaborative Networks: Engage in collaborative networks with other research institutions and industry partners to share data, best practices, and insights.

-Public Databases: Contribute to and utilize public databases of cardiotoxicity data to enhance the generalizability of findings and support broader research efforts.

-Treatment: Develop innovative approaches to treat cardiotoxicities with new oncology therapeutics.

-Natural history: Studies to investigate the natural history of various cardiotoxicities with new oncology therapeutics.

Eligibility

Small businesses; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Native American tribal governments (Federally recognized); For profit organizations other than small businesses; Private institutions of higher education; Public and State controlled institutions of higher education; Independent school districts; Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"; State governments; County governments; City or township governments; Native American tribal organizations (other than Federally recognized tribal governments); Public housing authorities/Indian housing authorities; Special district governments

Applying for grants? Grants Pro e-mails you every morning with the new grants and opened forecasts that match your saved searches, and adds deadline reminders in your calendar, a private RSS feed and CSV export. Try it free for 7 days, then $9/month, cancel any time. See what Pro does →

More from this funder: 12 open opportunities from Food and Drug Administration (FDA).

Applying? Read how to write a winning grant proposal.

Data from Grants.gov, US federal government (public domain). Last checked 19 Nov 2026. Always read the official page before applying: it has the full conditions, documents and how to apply.

Similar grants